抗生素使用作为各年龄段炎症性肠病风险因素:一项基于人群的队列研究
基于丹麦全国登记数据,纳入2000至2018年≥10岁居民共6104245人、随访87112328人年,新发炎症性肠病52898例。抗生素暴露与各年龄段炎症性肠病风险升高相关,40岁及以上人群风险最高,风险随累积暴露增加,靶向胃肠道病原体的抗生素及暴露后1-2年内风险最高。
要点
- 抗生素暴露与各年龄段炎症性肠病风险升高相关,40-60岁及≥60岁人群风险最高。
- 各年龄段均观察到阳性剂量反应关系,溃疡性结肠炎与克罗恩病结果相似。
- 抗生素暴露后1-2年内及使用靶向胃肠道病原体抗生素后炎症性肠病风险最高。
核心结论
- 抗生素暴露与炎症性肠病风险升高相关,40岁及以上人群风险最高。
- 该风险随累积抗生素暴露增加,在靶向胃肠道病原体的抗生素使用后及抗生素暴露后1-2年内更高。
研究设计与样本
- 利用丹麦全国登记数据建立2000至2018年≥10岁居民基于人群的队列。
- 采用泊松回归计算抗生素暴露后炎症性肠病的发病率比(IRR)。
主要发现
- 共纳入6104245人,随访87112328人年,新发炎症性肠病52898例。
- 与无抗生素暴露相比,各年龄段抗生素暴露均与炎症性肠病风险升高相关:10-40岁IRR 1.28(95%CI 1.25至1.32),40-60岁IRR 1.48(95%CI 1.43至1.54),≥60岁IRR 1.47(95%CI 1.42至1.53)。
- 各年龄段均观察到阳性剂量反应关系,溃疡性结肠炎与克罗恩病结果相似。
- 抗生素暴露后1-2年内及使用常用于治疗胃肠道病原体的抗生素类别后,炎症性肠病风险最高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an increasing incidence of inflammatory bowel disease (IBD) for which environmental factors are suspected. Antibiotics have been associated with development of IBD in earlier generations, but their influence on IBD risk in adults is uncertain. OBJECTIVE: To assess the impact of antibiotic exposure, including dose-response, timing and antibiotic class, on the risk of IBD in all individuals aged ≥10 years. DESIGN: Using Denmark nationwide registries, a population-based cohort of residents aged ≥10 years was established between 2000 and 2018. Incidence rate ratios (IRRs) for IBD following antibiotic exposure were calculated using Poisson regression. RESULTS: There were a total of 6 104 245 individuals, resulting in 87 112 328 person-years of follow-up, and 52 898 new cases of IBD. Antibiotic exposure was associated with an increased risk of IBD as compared with no antibiotic exposure for all age groups, although was greatest among individuals aged 40-60 years and ≥60 years (age 10-40 years, IRR 1.28, 95% CI 1.25 to 1.32; age 40-60 years, IRR 1.48, 95% CI 1.43 to 1.54; age ≥60 years, IRR 1.47, 95% CI 1.42 to 1.53). For all age groups a positive dose-response was observed, with similar results seen for both ulcerative colitis and Crohn's disease. The highest risk of developing IBD was seen 1-2 years after antibiotic exposure, and after use of antibiotic classes often prescribed to treat gastrointestinal pathogens. CONCLUSION: Antibiotic exposure is associated with an increased risk of IBD, and was highest among individuals aged 40 years and older. This risk increased with cumulative antibiotic exposure, with antibiotics targeting gastrointestinal pathogens and within 1-2 years after antibiotic exposure.
引用
- Faye AS, Allin KH, Iversen AT, et al. Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study. Gut. 2023. PMID: 36623926. doi:10.1136/gutjnl-2022-327845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。